Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

google.co.in

Google Alert - omalizumab

Get the latest updates from Google Alert - omalizumab directly as they happen.

Follow now 114 followers

Latest posts

Last updated 1 day ago

Biomed. 33 4; S0120-41572013000400003

1 day ago

DIEZ, Libia Susana; TAMAYO, Liliana María CARDONA, Ricardo. Omalizumab: opción terapéutica para...

Optionen bei chronischer spontaner Urtikaria - medonline.at

1 day ago

Die Behandlung der chronischen spontanen Urtikaria bleibt schwierig – vor allem, wenn...

Allergy Month in Review: June 2025 - HCPLive

1 day ago

A meta-analysis confirmed the safety of biologics like omalizumab for IgE-mediated food...

Q2 2025 Recap: Ophthalmology News and Updates - HCPLive

1 day ago

In chronic rhinosinusitis with nasal polyps and coexisting asthma, dupilumab proved superior...

Pulmonology Month in Review: June 2025 - HCPLive

2 days ago

Key Takeaways. Dupilumab outperformed omalizumab in the EVEREST trial for chronic rhinosinusitis...

150mg Omalirel Omalizumab Injection, Strength: 150 mg/ml - IndiaMART

2 days ago

Omalizumab Injection is a prescription medication most commonly marketed under the brand...

Efficacy and safety of CT-P39, an omalizumab biosimilar, in chronic spontaneous urticaria ...

3 days ago

Publikacja – Efficacy and safety of CT-P39, an omalizumab biosimilar, in chronic...

Kashiv BioSciences Reports Positive Topline Results for XOLAIR® Biosimilar Candidate ADL-018

3 days ago

... (omalizumab), in patients with chronic spontaneous urticaria. The study met both...

ΠΙΝΑΚΑΣ ΝΕΩΝ ΦΑΡΜΑΚΩΝ 1ου ΤΡΙΜΗΝΟΥ 2025

3 days ago

OMALIZUMAB. CELLTRION HEALTHCARE HUNGARY KFT., BUDAPEST,. HUNGARY. 6%. 338930101. 2803389301014. OMLYCLO INJ.SO.PFS...

Juan C Ivancevich MD on X: "#Omalizumab in #pediatric #chronic #spontaneous #urticaria ...

3 days ago

Omalizumab in #pediatric #chronic #spontaneous #urticaria: A systematic review and meta-analysis of...

EVEREST Trial Reveals Dupilumab's Superiority Over Omalizumab in CRSwNP with Asthma

3 days ago

... omalizumab in patients with severe CRSwNP and coexisting asthma. Dr De...

The Evolving Treatment Paradigm for Chronic Spontaneous Urticaria Management

3 days ago

... omalizumab, dupilumab, remibrutinib, and barselolizumab—with an emphasis on shared decision-making, patient...